护心康片通过AMPK/mTOR/p70S6K通路调控自噬改善大鼠慢性心力衰竭的作用机制OA
Huxinkang Tablets improves chronic heart failure in rats by regulating autophagy via AMPK/mTOR/p70S6K signaling pathway
目的 探讨护心康片调控自噬改善大鼠慢性心力衰竭的作用机制.方法 采用超高效液相色谱-四极杆-飞行时间串联质谱(UPLC-Q-TOF-MS/MS)技术从护心康片中鉴定出 19个主要化学成分,并结合网络药理学方法构建"成分-靶点-通路"作用网络,筛选出其作用于心力衰竭的30个核心靶点.经基因本体论(GO)及京都基因和基因组百科全书(KEGG)通路富集分析发现这些靶点显著富集于AMP依赖的蛋白激酶/哺乳动物雷帕霉素靶蛋白(AMPK/mTOR)自噬调控信号轴.在此基础上,通过结扎大鼠左冠状动脉前降支构建慢性心力衰竭模型,将48只大鼠随机分为空白组、模型组、卡托普利组(0.013 5 g/kg)以及护心康片低、中、高剂量组(0.41、0.82、1.64 g/kg),每组8只.连续给药4周后,检测血清中心房利钠肽(ANP)、B型脑钠尿肽(BNP)、超氧化物歧化酶(SOD)、丙二醛(MDA)、肿瘤坏死因子-α(TNF-α)、白细胞介素(IL)-6、IL-1β.采用Masson染色观察心肌病理改变,采用Western blot分析AMPK/mTOR/70 kDa核糖体蛋白 S6激酶(AMPK/mTOR/p70S6K)信号通路蛋白表达,系统验证网络药理学预测结果.结果 网络药理学预测核心靶点与AMPK/mTOR自噬通路高度相关.动物实验结果显示,模型组较空白组出现心肌纤维断裂、排列紊乱,左心室扩张伴左室射血分数(LVEF)显著降低(P<0.05),血清BNP、ANP、TNF-α、IL-6、IL-1β及MDA水平显著升高,SOD活性显著降低(P<0.05).Western blot结果显示,模型组心肌组织p-AMPK蛋白表达显著降低(P<0.01),p-mTOR、p-p70S6K、自噬标志物LC3-Ⅱ及p62蛋白表达显著升高(P<0.01).护心康片高剂量组可显著改善心肌病理损伤,减轻心室重构,提高LVEF,降低血清炎症及氧化应激标志物水平;同时,显著上调p-AMPK蛋白表达(P<0.01),下调p-mTOR、p-p70S6K、LC3-Ⅱ及p62蛋白水平(P<0.01).结论 护心康片所含多种活性成分可能通过作用于AMPK、mTOR等关键靶点,调控AMPK/mTOR/p70S6K信号通路,恢复心肌能量代谢稳态,促进自噬通路正常运行并缓解自噬流阻滞,从而减轻氧化应激与炎症反应,发挥心脏保护作用.
Objective To investigate the mechanism of Huxinkang Tablets in improving chronic heart failure(CHF)in rats via regulating autophagy.Methods Nineteen major chemical constitu-ents were identified from Huxinkang Tablets using ultra-performance liquid chromatography-quadru-pole-time-of-flight tandem mass spectrometry(UPLC-Q-TOF-MS/MS).A"component-target-pathway"interaction network was constructed using network pharmacology methods,and 30 core targets associated with heart failure were identified.Gene ontology(GO)and Kyoto Encyclopedia of Genes and Genomes(KEGG)pathway enrichment analyses revealed significant enrichment of these targets in the AMP-activa-ted protein kinase/mammalian target of rapamycin(AMPK/mTOR)autophagy regulatory signaling axis.A CHF model was established by ligating the left anterior descending coronary artery in rats.Forty-eight rats were randomly divided into six groups:blank,model,captopril(0.013 5 g/kg),and low-,medium-,and high-dose Huxinkang Tablet groups(0.41,0.82,and 1.64 g/kg,respectively),with eightrats in each group.After four weeks of continuous administration,serum levels of atrial na-triuretic peptide(ANP),B-type natriuretic peptide(BNP),superoxide dismutase(SOD),malon-dialdehyde(MDA),tumor necrosis factor-α(TNF-α),interleukin(IL)-6,and IL-1β were meas-ured.Masson staining was used to observe myocardial pathological changes,and Western blotting was performed to assess protein expression in the AMPK/mTOR/70 kDa ribosomal protein S6 kinase(AMPK/mTOR/p70S6K)signaling pathway,thereby systematically validating the network pharma-cology predictions.Results Network pharmacology predictions indicated a strong correlation be-tween core targets and the AMPK/mTOR autophagy pathway.Animal experiments revealed that the model group exhibited myocardial fiber rupture and disorganization,left ventricular dilation,and a significant reduction in left ventricular ejection fraction(LVEF)compared with the blank group(P<0.05).Serum levels of BNP,ANP,TNF-α,IL-6,IL-1β,and MDA were significantly ele-vated,while SOD activity was significantly decreased(P<0.05).Western blot results showed that p-AMPK protein expression in myocardial tissue was significantly reduced,whereas p-mTOR,p-p70S6K,the autophagy marker LC3-Ⅱ,and p62 protein expression were significantly increased in the model group(P<0.01).The high-dose Huxinkang Tablet group significantly improved myo-cardial pathological damage,alleviated ventricular remodeling,increased LVEF,and reduced serum levels of inflammatory and oxidative stress markers.Additionally,it significantly upregulated p-AMPK protein expression,and downregulated p-mTOR,p-p70S6K,LC3-Ⅱ,and p62 protein levels(P<0.01).Conclusion The multiple active constituents in Huxinkang Tablets may act on key targets such as AMPK and mTOR,regulate the AMPK/mTOR/p70S6K signaling pathway,re-store myocardial energy metabolism homeostasis,promote normal autophagy pathway function,and alleviate autophagic flux blockade,thereby reducing oxidative stress and inflammatory responses and exerting cardioprotective effects.
王凯丽;易艳;唐娜;赵虎;李莹莹;黄帅金
湖南省中西医结合医院,湖南长沙,410006湖南省中西医结合医院,湖南长沙,410006湖南省中西医结合医院,湖南长沙,410006湖南中医药大学,湖南长沙,410208湖南中医药大学,湖南长沙,410208湖南省中西医结合医院,湖南长沙,410006
医药卫生
护心康片慢性心力衰竭自噬AMP依赖的蛋白激酶哺乳动物雷帕霉素靶蛋白70 kDa核糖体蛋白S6激酶网络药理学超高效液相色谱-四极杆-飞行时间串联质谱
《实用临床医药杂志》 2026 (10)
58-67,75,11
湖南省2023年度中医药科研计划项目(C2023047)
评论